Prostate Cancer Clinical Trials in Michigan

Showing 201-220 of 288 trials

Saw Palmetto: Symptom Management for Men During Radiation Therapy

NCT01585246

The aim of this study is to test whether Saw Palmetto, is useful in preventing or reducing the side effects for men undergoing radiation therapy for prostate cancer. Urinary symptoms will be recorded each week, as well as assessment of quality of life through: 1) Physical Well-Being 2) Social/Family Well-being 3) Emotional Well-Being, and 4) Functional Well-Being.

Prostate Cancer

Michigan State University48 participantsStarted Oct 2011

Jackson, Michigan, United States • Lansing, Michigan, United States • Lansing, Michigan, United States +3 more locations

COMPLETEDPhase 1/225 miles

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

NCT00002602

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells and may be an effective treatment for prostate cancer. PURPOSE: Phase I/II trial to study the effectiveness of radiation therapy in treating patients who have previously untreated stage II or stage III prostate cancer.

Prostate Cancer

Radiation Therapy Oncology Group1,084 participantsStarted May 1994

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Mobile, Alabama, United States +225 more locations

Saw Palmetto: Symptom Management for Men During Radiation Therapy

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Prostate Cancer Trials in Other Cities

Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer

Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T

Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.

Firmagon (Degarelix) Intermittent Therapy

Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide

A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)

Doxercalciferol Before Surgery in Treating Localized Prostate Cancer

Multi-Institutional Registry for Prostate Cancer Radiosurgery

OGX-427 in Castration Resistant Prostate Cancer Patients

CHESS: Human and Computer Mentors for Prostate Cancer Patients

A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors

Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303)

Vidaza to Restore Hormone Thx Prostate

Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer

A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer

Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC)

Other Conditions in Michigan